SIGN UP
LOG IN
BRIEF-China Biotech Services Expected To Record Net Loss Attributable Of About HK$65 Mln For 9M
Reuters·10/31/2023 09:58:26
Listen to the news
Oct 31 (Reuters) - China Biotech Services Holdings Ltd 8037.HK:
GROUP EXPECTED TO RECORD A NET LOSS ATTRIBUTABLE ABOUT HK$65 MILLION FOR 9M
EXPECTED RESULT DUE TO DECLINES IN DEMAND FOR GROUP'S COVID-19 NUCLEIC ACID TESTING SERVICES, AMONG OTHERS
EXPECTED RESULT DUE TO DECLINES IN DEMAND FOR GROUP'S COVID-19 NUCLEIC ACID TESTING SERVICES
Source text for Eikon: [ID:]
Further company coverage: 8037.HK
Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
① During the campaign period from July 1, 2023 to June 30, 2024 US stocks, US stocks short selling, US stock options, Hong Kong stocks, and A-shares trading will maintain at $0 commission, and no subscription/redemption fees for mutual fund transactions. For more information, please visit: https://www.webull.hk/pricing
② More than 40M Downloads Globally : data based on Webull Technologies Limited's internal statistics as of July 14, 2023.
③ Pre-market (4:00 AM - 9:30 AM ET) , after-hours (4:00 PM - 8:00 PM ET) .
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
① During the campaign period from July 1, 2023 to June 30, 2024 US stocks, US stocks short selling, US stock options, Hong Kong stocks, and A-shares trading will maintain at $0 commission, and no subscription/redemption fees for mutual fund transactions. For more information, please visit: https://www.webull.hk/pricing
② More than 40M Downloads Globally : data based on Webull Technologies Limited's internal statistics as of July 14, 2023.
③ Pre-market (4:00 AM - 9:30 AM ET) , after-hours (4:00 PM - 8:00 PM ET) .
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language
English
©2024 Webull Securities Limited. All rights reserved.